Intense immunosuppression and stem cell transplantation or rescue for severe systemic lupus erythematosus

A New Combination of Idarubicin, Etoposide and Cytarabine in Untreated Acute Non-Lymphoblastic Leukemia.

Leukemia & lymphoma·2016

Patients with systemic lupus erythematosus (SLE) having developed malignant lymphomas. Complete remission of lymphoma following high-dose chemotherapy, but not of SLE.

Clinical and experimental rheumatology·2011

Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome.

Autoimmunity·2006

Long term complete remission of severe nephrotic syndrome secondary to diffuse global (IV-G) lupus nephritis following autologous, haematopoietic peripheral stem (CD34+) cell transplantation.

Lupus·2006

The promise of hematopoietic stem cell transplantation for autoimmune diseases.

Bone marrow transplantation·2003

Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect.

Bone marrow transplantation·2003

Global prevalence and associated factors of metabolic syndrome in patients with systemic lupus erythematosus: A systematic review and meta-analysis.

Lupus·2026

Views on pregnancy and related concerns among women with systemic lupus erythematosus: A cross-sectional study.

Lupus·2026

Clinical characteristics of patients with primary antiphospholipid syndrome and "single" antiphospholipid antibody: Retrospective results from the APS ACTION clinical database and repository ("registry").

Lupus·2026

A structured primary care-led triage and referral pathway for systemic lupus erythematosus: Operational criteria and referral outcomes from a real-world rheumatology practice.

Lupus·2026

Uncertainty in illness and psychological adjustment in patients with systemic lupus erythematosus.

Lupus·2026

Clinical characteristics of patients with late-onset systemic lupus erythematosus with a disease onset of ≤ 3 months.

Lupus·2026

Integrated Traditional Chinese and Western Medicine for Severe Tislelizumab-Induced Rash: A Case Report.

Case reports in oncology·2026

Glucocorticoids combined with rituximab treatment for IgG4-related tubulointerstitial nephritis with diabetic nephropathy: a case report.

Open medicine (Warsaw, Poland)·2026

Quality Assessment of an Immunotherapy Toxicity Clinic: A Clinical Audit at Castle Hill Hospital Evaluating Adherence to Clinical Guidelines, Documentation Standards, and Clinical Outcomes.

Cureus·2026

Characterization of Histologic Spectrum and T-Cell Clonality in Immune Effector Cell-Associated Enteritis.

Human pathology·2026

CD20 targeted nanomedicine enhances anti-tumor immunity in diffuse large B-cell lymphoma by activating cGAS/STING pathway.

Cancer letters·2026

Effects of anion excipients on the viscosity of high-concentration mAb solution.

Journal of pharmaceutical sciences·2026

Related Experiment Videos

Intense immunosuppression and stem cell transplantation or rescue for severe systemic lupus erythematosus

Related Concept Videos

A New Combination of Idarubicin, Etoposide and Cytarabine in Untreated Acute Non-Lymphoblastic Leukemia.

Patients with systemic lupus erythematosus (SLE) having developed malignant lymphomas. Complete remission of lymphoma following high-dose chemotherapy, but not of SLE.

Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome.

Long term complete remission of severe nephrotic syndrome secondary to diffuse global (IV-G) lupus nephritis following autologous, haematopoietic peripheral stem (CD34+) cell transplantation.

The promise of hematopoietic stem cell transplantation for autoimmune diseases.

Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect.

Global prevalence and associated factors of metabolic syndrome in patients with systemic lupus erythematosus: A systematic review and meta-analysis.

Views on pregnancy and related concerns among women with systemic lupus erythematosus: A cross-sectional study.

Clinical characteristics of patients with primary antiphospholipid syndrome and "single" antiphospholipid antibody: Retrospective results from the APS ACTION clinical database and repository ("registry").

A structured primary care-led triage and referral pathway for systemic lupus erythematosus: Operational criteria and referral outcomes from a real-world rheumatology practice.

Uncertainty in illness and psychological adjustment in patients with systemic lupus erythematosus.

Clinical characteristics of patients with late-onset systemic lupus erythematosus with a disease onset of ≤ 3 months.

Integrated Traditional Chinese and Western Medicine for Severe Tislelizumab-Induced Rash: A Case Report.

Glucocorticoids combined with rituximab treatment for IgG4-related tubulointerstitial nephritis with diabetic nephropathy: a case report.

Quality Assessment of an Immunotherapy Toxicity Clinic: A Clinical Audit at Castle Hill Hospital Evaluating Adherence to Clinical Guidelines, Documentation Standards, and Clinical Outcomes.

Characterization of Histologic Spectrum and T-Cell Clonality in Immune Effector Cell-Associated Enteritis.

CD20 targeted nanomedicine enhances anti-tumor immunity in diffuse large B-cell lymphoma by activating cGAS/STING pathway.

Effects of anion excipients on the viscosity of high-concentration mAb solution.

Related Experiment Videos

Intense immunosuppression and stem cell transplantation or rescue for severe systemic lupus erythematosus

Related Concept Videos

Related Articles